The company maintains close ties with clinical research institutions and scientific research academies, forming a research team focused on the prevention and treatment of cardiovascular and cerebrovascular diseases. Always adhering to continuous innovation as a strategic approach to enhance its core competitiveness, the company has developed a research culture of innovative development tailored to public health needs and established a corresponding research management system, creating a favorable innovative atmosphere for researchers. In collaboration with clinical research institutions, it has developed ischemic preconditioning training devices, opening up a new pathway for the prevention and treatment of cardiovascular and cerebrovascular diseases. The company has won numerous awards, including the Second Prize of National Scientific and Technological Progress, the First Prize of Scientific and Technological Progress awarded by the Ministry of Education, the Stroke Innovation Award from the United States, and the Medical Industry Development and Innovation Award. It holds invention patents in China, the United States, and Japan. Due to its simple training method, lack of surgical risk, and low recurrence rate, especially for elderly patients and those intolerant to surgery, it provides a new and effective treatment method. It is considered one of the most promising preventive and therapeutic means for ischemic cardiovascular and cerebrovascular diseases.

Currently, hundreds of tertiary medical institutions in other provinces and cities have applied ischemic preconditioning training technology for the prevention and treatment of cerebrovascular diseases and related conditions. Larger medical institutions include West China Hospital of Sichuan University, Huashan Hospital of Fudan University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, The First Affiliated Hospital of Sun Yat-sen University, Qilu Hospital of Shandong University, Shandong Provincial Hospital, The First Affiliated Hospital of Xi'an Jiaotong University, and Northern War Zone General Hospital of Liaoning Province (already covered by Liaoning Provincial Medical Insurance). In Beijing, ischemic preconditioning training is applied in dozens of medical institutions (including tertiary and secondary medical institutions), with representative tertiary medical institutions including Xuanwu Hospital of Capital Medical University, Tiantan Hospital Affiliated to Capital Medical University, Peking Union Medical College Hospital, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing Luhe Hospital Affiliated to Capital Medical University, Beijing Shijitan Hospital Affiliated to Capital Medical University, Beijing Boai Hospital, and Aerospace Center Hospital.